V. Petrakis

发表

Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial

H. Milionis, E. Michelakis, E. Giamarellos‐Bourboulis, 2021, Infectious Diseases and Therapy.

Calprotectin and inflammation-associated serum biomarkers determine critical illness in COVID-19

E. Giamarellos‐Bourboulis, T. Gkavogianni, S. Metallidis, 2022, medRxiv.

Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19

H. Milionis, E. Giamarellos‐Bourboulis, T. Gkavogianni, 2022, International journal of molecular sciences.

Lymphoid interstitial pneumonitis in a newly diagnosed late presenter of human immunodeficiency virus infection: a case report

D. Papazoglou, P. Ntolios, P. Panagopoulos, 2021, Journal of Medical Case Reports.

Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

M. Netea, G. Chatellier, M. Sormani, 2021, The Lancet Rheumatology.

Early start of oral clarithromycin is associated with better outcome in COVID-19 of moderate severity: the ACHIEVE open-label trial

H. Milionis, E. Michelakis, E. Giamarellos‐Bourboulis, 2020 .

Oral clarithromycin in COVID-19 of moderate severity: the ACHIEVE open-label trial using concurrent matched comparators

K. Syrigos, H. Milionis, E. Michelakis, 2020, medRxiv.

Diabetes Mellitus and Hypertension as Major Risk Factors of Mortality From Covid-19 Pneumonia.

D. Papazoglou, N. Papanas, P. Panagopoulos, 2020, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

An open label trial of anakinra to prevent respiratory failure in COVID-19

M. Netea, H. Milionis, J. van der Meer, 2020, medRxiv.

Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial

E. Nicastri, L. Dagna, H. Milionis, 2022, eClinicalMedicine.

Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia

K. Syrigos, E. Nicastri, L. Dagna, 2022, Cytokine.

Quality of sleep in people living with HIV in the era of highly active antiretroviral treatment

D. Papazoglou, P. Steiropoulos, N. Papanas, 2022, International journal of STD & AIDS.

Fasting Plasma Glucose Increase and Neutrophil-to-Lymphocyte Ratio as Risk Predictors of Clinical Outcome of COVID-19 Pneumonia in Type 2 Diabetes Mellitus

D. Papazoglou, N. Papanas, G. Trypsianis, 2022, Experimental and Clinical Endocrinology & Diabetes.

Diabetes Mellitus as the Major Factor of Prolonged Hospitalisation in Mild or Moderate COVID-19 Pneumonia.

D. Papazoglou, N. Papanas, G. Trypsianis, 2021, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Clinical Phenotyping for Prognosis and Immunotherapy Guidance in Bacterial Sepsis and COVID-19

N. Rovina, E. Giamarellos‐Bourboulis, I. Koutsodimitropoulos, 2024, Critical care explorations.

Testing Hepatitis E Seroprevalence among HIV-Infected Patients in Greece: The SHIP Study

K. Akinosoglou, D. Kofteridis, S. Metallidis, 2024, Pathogens.